Growth Hormone Peptides Marketed as Anti-Aging Treatments Face Scientific Scrutiny

Growth hormone peptides, including sermorelin and tesamorelin, are increasingly being promoted as treatments that can slow or reverse aging, according to an article published by Scientific American.

The publication reports that these compounds, which are designed to stimulate the body's natural production of growth hormone, have gained popularity as purported anti-aging therapies, sometimes referred to as longevity treatments.

According to Scientific American, the growing interest in these peptides has prompted questions about whether the scientific evidence supports the claims being made about their effects on aging.

The article notes that sermorelin and tesamorelin are among several growth hormone-releasing peptides that have drawn attention in wellness and longevity circles, with proponents suggesting benefits ranging from improved body composition to broader anti-aging effects.

Scientific American's examination raises the question of whether current research substantiates the marketing claims surrounding these peptides, though the publication indicates that the scientific basis for many of the touted benefits remains a subject of ongoing scrutiny.

The full assessment of the evidence, including specific studies and expert perspectives referenced in the original report, can be found in the complete article published by Scientific American.